Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer

Oncology Letters

Volumn 1, Issue 5, 2010, Pages 837-840

  Inoue, Yoshimasa ^a   Matsumoto, Hozumi ^b   Yamada, Shunsuke ^c   Kawai, Kenji ^b   Suemizu, Hiroshi ^b   Gika, Masatoshi ^d   Takanami, Iwaowao ^e   Iwazaki, Masayuki ^f   Nakamura, Masatoasato ^b,f  

^a Ikegami General Hospital   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Drug resistance; Non small cell lung cancer

Indexed keywords

CISPLATIN; MENKES PROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CHEMOSENSITIVITY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MALE; REAL TIME POLYMERASE CHAIN REACTION;

EID: 77957577258     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000147     Document Type: Article

References (17)

1. Perez RP: Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 34: 1535-1542, 1998.
2. Tiseo M, Franciosi V, Grossi F and Ardizzoni A: Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice? Eur J Cancer 42: 8-16, 2006.
3. Terada K, Nakako T, Yang XL, et al: Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem 273: 1815-1820, 1998.
4. Chelly J, Tumer Z, Tonnesen T, et al: Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet 3: 14-19, 1993.
5. Mercer JF, Livingston J, Hall B, et al: Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet 3: 20-25, 1993.
6. Vulpe C, Levinson B, Whitney S, Packman S and Gitschier J: Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 3: 7-13, 1993.
7. Safaei R, Holzer AK, Katano K, Samimi G and Howell SB: The role of copper transporters in the development of resistance to Pt drugs. J Inorg Biochem 98: 1607-1613, 2004.
8. Petris MJ, Strausak D and Mercer JF: The Menkes copper transporter is required for the activation of tyrosinase. Hum Mol Genet 9: 2845-2851, 2000.
9. Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS and Howell SB: Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin Cancer Res 9: 5853-5859, 2003.
10. Samimi G, Safaei R, Katano K, et al: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10: 4661-4669, 2004.
11. Safaei R, Katano K, Samimi G, et al: Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother Pharmacol 53: 239-246, 2004.
12. Kobayashi H, Higashiyama M, Minamigawa K, et al: Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn J Cancer Res 92: 203-210, 2001.
13. Kobayashi H: Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness. Recent Results Cancer Res 161: 48-61, 2003.
14. Kawamura M, Gika M, Abiko T, et al: Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol 59: 507-513, 2007.
15. Nakagawa T, Inoue Y, Kodama H, et al: Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts. Oncol Rep 20: 265-270, 2008.
16. Nishi M, Abe Y, Fujimori S, et al: The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small-cell lung cancer xenografts in vivo. Oncol Rep 14: 421-424, 2005.
17. Fujimori S, Abe Y, Nishi M, et al: The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo. Int J Oncol 25: 413-418, 2004.